By Dr. Brandon Bright, DAOM, LAc · Doctor of Acupuncture & Oriental Medicine · Functional Medicine University-certified · Tustin, CA · Last reviewed: August 31, 2026
Oura had quite a week in late August. On August 21, the company was hit with a class-action lawsuit alleging its sleep-staging claims overstate what the ring actually measures. Days later, Bloomberg reported Oura is preparing a US IPO of up to $3 billion at a valuation north of $16 billion — possibly as soon as September. Both things can be true at once: the market believes wearable health data is enormously valuable, and the accuracy of that data is now being contested in court. If you wear an Oura, WHOOP, Apple Watch, or any sleep tracker — and especially if you make daily decisions based on its scores — this is the patient-level guide to what that data can and cannot support. To be clear up front: the lawsuit’s claims are unresolved allegations, Oura disputes them, and nothing here assumes the outcome.
The 55-second answer
Consumer sleep trackers are good at trends, weak at absolutes, and weakest exactly where the marketing is boldest: sleep staging. Wearables estimate sleep from movement, heart rate, HRV, and temperature — they do not measure brain activity, which is what actually defines sleep stages. Against polysomnography (the lab gold standard), consumer devices detect whether you’re asleep reasonably well, but their deep/REM/light staging agreement is moderate at best. Practical translation: your tracker’s trend (sleep worsening over three weeks, HRV drifting down) is real signal worth acting on; any single night’s “deep sleep minutes” or a daily readiness score is an estimate with real error bars, not a diagnosis. The lawsuit — whatever its outcome — is forcing a conversation the wearable category has needed for years: the gap between measurement and marketing.
What happened, precisely
- August 21, 2026: a class-action complaint was filed alleging Oura’s sleep-accuracy marketing overstates the ring’s staging capabilities. These are allegations; no court has ruled; Oura disputes the claims.
- August 24–25, 2026: multiple outlets reported Oura is preparing a US IPO of up to $3B at a valuation above $16B, possibly filing as soon as September. If and when the S-1 becomes public, its risk-factors section will contain the company’s own legal characterization of the accuracy question — worth reading directly.
The juxtaposition is the story: wearable health data commands a eleven-figure valuation at the same moment its core consumer claim is under legal scrutiny. For patients, the takeaway isn’t “wearables are fake” — it’s that the interpretation layer around wearable data matters more than the device.
What sleep trackers measure vs. what they claim
Sleep stages — light, deep (slow-wave), and REM — are defined by brain electrical activity, measured in a lab with EEG electrodes as part of polysomnography. No ring or watch measures brain activity. Consumer wearables infer stages from proxies: movement, heart rate, heart-rate variability, respiratory rate, and skin temperature. Inference from proxies can be surprisingly decent — and it is still inference.
The validation literature across consumer devices consistently shows a pattern: good detection of sleep vs. wake (the device usually knows you were asleep), reasonable total-sleep-time estimates, and moderate-to-weak agreement on staging — with deep sleep the most error-prone, and accuracy degrading further in people with fragmented sleep. Which is a meaningful irony: the population most anxious about their sleep data — poor sleepers — is the population the staging algorithms handle worst. This applies category-wide, not to any single brand. (For the broader picture of what consumer devices can and can’t measure across all metrics, see the wearables capability guide.)
How to actually use your sleep data
Trust the trends
A three-week decline in your sleep score, a falling HRV baseline, rising resting heart rate, growing night-waking counts — these trend signals are where wearables genuinely shine, because systematic error cancels out when you compare a device against itself. In clinic, a patient’s wearable trend line frequently surfaces the problem (perimenopausal sleep fragmentation, overtraining, alcohol creep, a stress load spike) before they’ve consciously registered it.
Discount the absolutes
“You got 43 minutes of deep sleep” is an estimate that could be off substantially in either direction. Don’t chase single-night stage numbers, and don’t let a bad readiness score override how you actually feel — score anxiety is real (researchers have a name for it: orthosomnia) and it measurably worsens sleep. If your tracker is making you sleep worse, that’s a signal too.
Know what the device can’t see
A wearable cannot diagnose sleep apnea (loud snoring, gasping, witnessed pauses need a real sleep study — and apnea risk rises sharply for women in perimenopause), can’t distinguish why sleep is fragmenting (hormones? cortisol? blood sugar? environment?), and has no idea about your context — a perimenopausal woman’s hormonally fragmented sleep reads as a fitness-recovery problem to an algorithm trained on the general population.
Bring the data to a human who can interpret it
This is the layer the lawsuit indirectly spotlights: data collection is commoditized; interpretation is not. A falling HRV trend means something different in an overtrained athlete, a perimenopausal patient, and someone with untreated apnea. At the Tustin practice we read wearable trends alongside labs, symptoms, and history — the sleep-architecture work described in the perimenopause sleep guide routinely starts from a patient’s own Oura or WHOOP export. The device is a useful witness. It shouldn’t be the judge.
Should you stop wearing your ring?
No — not on the basis of an unresolved lawsuit, and not on the basis of this article. Keep the device; recalibrate the relationship: trends over absolutes, feelings over scores on any given day, and a clinician in the loop when the trend line says something is actually wrong. If the S-1 files, read the risk factors — companies are at their most honest about their products’ limits in that section.
Frequently asked questions
Is the Oura ring accurate?
For sleep/wake detection and trend tracking, reasonably. For minute-level sleep staging, no consumer wearable matches lab polysomnography, and the accuracy question is now the subject of unresolved litigation. Use it for trends.
Which sleep tracker is most accurate?
Differences between the major devices are smaller than the gap between all of them and a sleep lab. Pick on comfort and ecosystem; treat staging data from any of them as an estimate.
My readiness score is low but I feel fine. Who’s right?
You are. The score is an inference from proxies; your felt state integrates information no wearable has. Chronic mismatch between scores and feelings is worth investigating — in either direction.
Can my tracker tell me if I have sleep apnea?
No. Some devices flag breathing irregularities, but diagnosis requires a sleep study. Loud snoring, gasping, witnessed pauses, or unrefreshing sleep despite adequate hours — especially in perimenopause — warrant a physician referral.
Should the lawsuit change anything I do?
Only this: hold every wearable’s marketing claims — any brand — to the “trends, not absolutes” standard. The litigation will resolve on its own timeline; the practical guidance doesn’t depend on the verdict.
Dr. Brandon Bright is a Doctor of Acupuncture and Oriental Medicine (DAOM), Licensed Acupuncturist in California, and Functional Medicine University-certified. He runs a multi-modality holistic medicine practice at 13732 Newport Ave STE 2, Tustin, CA 92780. Phone: 714-206-7883. He has no financial relationship with Oura, WHOOP, Apple, or any wearable maker. He is not a medical doctor. The lawsuit described is an unresolved legal allegation, not a finding of wrongdoing. This article is educational and not a substitute for individualized medical advice; suspected sleep disorders warrant evaluation by a physician.